RxDoctor Payments Data

Judy Johnson, NP

Psychiatric/Mental Health · Spartanburg, SCNPI 1932615655

Payments from drug & device makers

$2,949in general payments, 2019–2025

Across 144 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$408
  • Otsuka America Pharmaceutical, Inc.$359
  • Axsome Therapeutics, Inc.$326
  • E.r. Squibb & Sons, L.L.C.$313
  • Lundbeck LLC$304
  • Takeda Pharmaceuticals U.S.A., Inc.$263
  • plus $975 from 13 others

What the payments were for

  • Food & beverage$2,90999%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,949 in reported general payments places this provider in the 80th percentile of 354 psychiatric/mental health providers in South Carolina.

See all psychiatric/mental health providers in South Carolina

Medicare billing

Part B allowed, 2024
$13,985
Medicare patients
66
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine11$45,324
Ramelteon18$2,184
Aripiprazole28$1,103
Olanzapine50$1,047
Hydroxyzine Hcl45$1,005
Mirtazapine41$790
Duloxetine Hcl32$597
Clonazepam60$565
Quetiapine Fumarate77$527
Venlafaxine Hcl ErVenlafaxine Hcl24$488
Risperidone47$431
Buspirone Hcl35$379
Eszopiclone15$372
Prazosin Hcl26$348
Trazodone Hcl67$308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$14$45,32411 claims
Lilly USA, LLCOlanzapine$14$1,04750 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 354 psychiatric/mental health providers in South Carolina.

Other psychiatric/mental health in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →